Dynamics of a bacterial multidrug ABC transporter in the inward- and outward-facing conformations. by Mehmood, Shahid et al.
Dynamics of a bacterial multidrug ABC transporter in
the inward- and outward-facing conformations.
Shahid Mehmood, Carmen Domene, Eric Forest, Jean-Michel Jault
To cite this version:
Shahid Mehmood, Carmen Domene, Eric Forest, Jean-Michel Jault. Dynamics of a bacterial
multidrug ABC transporter in the inward- and outward-facing conformations.. Proceedings
of the National Academy of Sciences of the United States of America , National Academy of
Sciences, 2012, 109 (27), pp.10832-6. <10.1073/pnas.1204067109>. <hal-01004601>
HAL Id: hal-01004601
https://hal.archives-ouvertes.fr/hal-01004601
Submitted on 11 Jun 2014
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
Dynamics of a bacterial multidrug ABC transporter in
the inward- and outward-facing conformations
Shahid Mehmooda,b,c, Carmen Domened, Eric Foresta,b,c,1, and Jean-Michel Jaulta,b,c,1
aInstitut de Biologie Structurale, Université Joseph Fourier Grenoble 1, 38027 Grenoble Cedex 1, France; bCommissariat à l’Energie Atomique et aux Energies
Alternatives Grenoble, 38027 Grenoble Cedex 1, France; cUnité Mixte de Recherche 5075, Centre National de la Recherche Scientiﬁque, 38027 Grenoble
Cedex 1, France; and dDepartment of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, Oxford OX1 3QZ, United Kingdom
Edited by H. Ronald Kaback, University of California, Los Angeles, CA, and approved May 18, 2012 (received for review March 8, 2012)
The study of membrane proteins remains a challenging task, and
approaches to unravel their dynamics are scarce. Here, we applied
hydrogen/deuteriumexchange (HDX) coupled tomass spectrometry
to probe the motions of a bacterial multidrug ATP-binding cassette
(ABC) transporter, BmrA, in the inward-facing (resting state) and
outward-facing (ATP-bound) conformations. Trypsin digestion and
global or local HDX support the transition between inward- and
outward-facing conformations during the catalytic cycle of BmrA.
However, in the resting state, peptides from the two intracellular
domains, especially ICD2, showamuch faster HDX than in the closed
state. This shows that these two subdomains are veryﬂexible in this
conformation. Additionally, molecular dynamics simulations sug-
gest a large ﬂuctuation of the Cα positions from ICD2 residues in the
inward-facing conformation of a related transporter, MsbA. These
results highlight the unexpected ﬂexibility of ABC exporters in the
resting state and underline the power of HDX coupled tomass spec-
trometry to explore conformational changes and dynamics of large
membrane proteins.
ATPase cycle | structural biology | detergent
Import of nutrients and export of signaling molecules or noxiouscompounds are essential processes for life, and selectivity for
crossing membrane is usually governed by dedicated transporters.
The ATP-binding cassette (ABC) is one of the largest families of
transporters involved in these “checkpoints.” They are found in
all living species and use ATP hydrolysis to transport a wide va-
riety of substrates (1). The dysfunctions of several ABC trans-
porters cause severe pathologies, such as adrenoleukodystrophy,
hyperinsulinemic hypoglycemia, or cystic ﬁbrosis (2). Other
medically important ABC transporters are responsible for mul-
tidrug resistance (MDR) phenotypes. Multidrug transporters are
capable of recognizing and expelling many unrelated organic
compounds with quite dissimilar chemical scaffolds. Thus, al-
though their original function is to protect healthy cells, the oc-
currence of these transporters in malignant tissues, pathogenic
microorganisms, or parasites confers a resistance toward the cu-
rative drugs. The archetype of multidrug ABC transporters is the
human MDR1 (or ABCB1); it is responsible for the failure of
chemotherapeutic treatments in cancerous tissues. In bacteria,
the identiﬁcation of related transporters is relatively recent,
compared with other families of multidrug transporters that use
the proton gradient as the energy source (3). However, growing
bodies of evidence support the implication of these multidrug
ABC transporters in antibiotic resistance in many species, jeop-
ardizing a successful therapy (4).
All ABC transporters share a common architecture, with two
transmembrane domains (TMDs) responsible for substrate
translocation and two nucleotide-binding domains (NBDs). In
most exporters, these four domains are either linked into a single
polypeptide or function as dimers with one NBD fused to one
TMD (homo- or heterodimers). As opposed to the TMDs, the
NBDs are highly conserved, with several distinctive motifs, no-
tably the Walker A and Walker B found in many ATPases and
the ABC signature speciﬁc to this family (5, 6). NBD structures
have shown that during the catalytic cycle, the two NBDs interact
transiently to form a sandwich dimer in a head-to-tail fashion,
thereby trapping two ATP molecules at their interface (7–9). In
this closed conformation, which can be stabilized either by
ATPase-inactive mutations (10) or by vanadate-induced ADP
trapping (11), each composite ATP-binding site is made of ele-
ments from one NBD (i.e., Walker A and B motifs), whereas the
ABC signature is provided in trans by the second NBD. The
overall structure of exporters is less compact than that of
importers with two large intracellular domains (ICDs), ICD1 and
ICD2, which protrude from the TMD to interact with the NBD.
Importantly, whereas ICD1 from one monomer interacts with its
own NBD, ICD2 (or ICD4 for full-length exporters) interacts
mainly with the NBD of the other monomer (or other moiety)
(12–14), and this has been validated by cross-linking experiments
(15, 16). Snapshots of 3D structures and electron paramagnetic
resonance (EPR) spectroscopy suggest that large motions occur
during the catalytic cycle of ABC exporters, with the transporter
oscillating between an apo, open (or inward-facing), conforma-
tion, with its two NBDs lying far apart, and an ATP-bound closed
(or outward-facing) conformation, with the NBDs engaged in
a tight interaction (12–14, 17). However, the open structures
have raised some skepticism and were proposed to reﬂect non-
physiological states of the proteins, possibly induced by the
presence of detergent (18, 19). Importantly, in all of the struc-
tures solved, the contacts between ICDs and NBDs are always
maintained, because these two domains keep the same overall
conformation and interactions. This suggests that NBD closure
operates by a rigid body motion (12, 14). On the other hand,
cross-linking experiments between ICDs and NBDs give support
to alternative conformations for these two domains in different
ABC exporters (15, 16, 20, 21).
To shed light on structural modiﬁcations that might occur
during the mechanism of ABC transporters, we used a hydrogen/
deuterium exchange (HDX) approach coupled to mass spec-
trometry (MS). HDX has been widely used on soluble proteins to
probe the accessibility of backbone amides, thus highlighting
secondary structure modiﬁcations at the peptide level (22, 23).
For membrane proteins, this approach is only beginning to
emerge (24–26), but its usefulness has been demonstrated, for
example, to pinpoint the conformational changes associated with
the binding of ligands, agonists, or antagonists, to the β-2-ad-
renergic receptor GPCR (27). Given the importance of mem-
brane proteins, our results emphasize the beneﬁt of using HDX
to address fundamental issues about their functioning. Here, it
revealed the dynamics of a multidrug transporter homologous to
Author contributions: C.D., E.F., and J.-M.J. designed research; S.M. and C.D. performed
research; S.M., C.D., E.F., and J.-M.J. analyzed data; and E.F. and J.-M.J. wrote the paper.
The authors declare no conﬂict of interest.
This article is a PNAS Direct Submission.
1To whom correspondence may be addressed. E-mail: eric.forest@ibs.fr or jean-michel.
jault@ibs.fr.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1204067109/-/DCSupplemental.
10832–10836 | PNAS | July 3, 2012 | vol. 109 | no. 27 www.pnas.org/cgi/doi/10.1073/pnas.1204067109
MsbA, Sav1866, and to murine MDR1 (28, 29). In particular, it
showed that the two ICDs of BmrA behave quite differently,
depending on the conformational state considered, and are un-
expectedly highly ﬂexible in the resting state. These results ex-
tend our vision of the functioning mechanism of ABC exporters
and complement the snapshots of the catalytic cycle acquired
from high-resolution 3D structures.
Results
BmrA Switches Between Two Opposite Conformations. 3D structures
of ABC exporters solved in the presence of detergent have sug-
gested that large conformational changes might occur during the
ATPase cycle (12, 14). To investigate this, we checked whether the
presence of detergent affected the conformational changes that
take place during the catalytic cycle of BmrA. In agreement with
our previous results (30), the ATPase activity of BmrA was con-
served in a detergent solubilized state and sensitive to vanadate
inhibition (Fig. S1). Then, global HDX was performed on the
protein either puriﬁed in detergent or in a membrane environment
previously shown to preserve the functional state of the transporter
(29). The deconvoluted masses obtained from electrospray of
BmrA, either embedded in membrane (66,341 ± 3 Da) or puriﬁed
in n-dodecyl-β-D-maltoside (DDM) (66,339 ± 3 Da), are in very
good agreement with the theoretical mass of BmrA, possessing
only one extra Ser amino acid on its N terminus (66,340 Da; Fig.
S2). The other peaks of lower intensity were due to sequence
heterogeneity (SI Results) and unidentiﬁed noncovalent adducts
on both forms of BmrA.
After incubation of BmrA preparations in deuterated buffers,
the mass of deuterated BmrA was measured. The percentage of
deuterated amides was calculated, taking into account the aver-
age of total number of amide hydrogens in BmrA (585 for the
native protein) and the mass increase. Curves for deuteration
kinetics show the same behavior, with the exchange steadily in-
creasing with time for BmrA in both states (Fig. 1). However,
BmrA in membranes was approximately half less deuterated (13–
23%) than in its solubilized form (23–47%). This lower deuter-
ation exchange in membrane could possibly reﬂect a more com-
pact conformation of the BmrA dimer. However, when the same
experiment was performed after prior incubation of BmrA with
vanadate in the presence of ATP-Mg (closed symbols in Fig. 1)
[i.e., conditions known to promote the formation of a closed di-
mer (11)], a lower deuteration level was found for BmrA either in
membrane (squares in Fig. 1) or in detergent (circles in Fig. 1).
Thus, although HDX occurs at approximately twice the rate in
detergent compared with the membrane-bound BmrA, vanadate
inhibition induced a signiﬁcant decrease in HDX, to a similar
extent for both environments. Therefore, this shows that in either
state, BmrA can switch between two different conformations: an
apo one whereby deuterium exchange readily occurs and a closed
one more resistant to deuterium exchange.
To bring further evidence for the similar behavior of BmrA in
detergent and membranes, limited digestion with trypsin was
carried out. BmrA in the apo conformation was rapidly digested
by trypsin in membranes as well as in DDM (Fig. S3). In contrast,
in the closed conformation (+Vi), BmrA was quite resistant to
this protease in both environments. Thus, regardless of its en-
vironment, BmrA adopts two different conformations with op-
posite sensitivity to trypsin.
Peptide Mapping of BmrA. To achieve a sequence coverage as
large as possible, local HDX was performed on puriﬁed BmrA
because (i) a much higher deuteration level was found for the
protein in detergent, and (ii) the presence of Escherichia coli
proteins in the membrane fraction would hamper the un-
ambiguous identiﬁcation, or the determination of deuterium
incorporation, for some BmrA peptides. Optimized conditions
led to a sequence coverage of 78% using pepsin (Table S1). It
was lower in the TMD (60%), with the majority of the identiﬁed
peptides belonging to the hydrophilic ICDs, ICD1 and ICD2
(Fig. S4). In contrast, the NBD sequence was almost fully cov-
ered by the pepsin digestion (98%). Because deuteration in-
duced the spreading of isotopic envelopes (i.e., the ensemble of
isotopic peaks of a peptide), it often led to signal decrease and
overlapping. Thus, a signiﬁcant number of peptides were lost
after deuteration, giving 45% and 92% coverage for TMD and
NBD, respectively. Importantly, most of the two ICDs were still
covered by HDX because these two subdomains are essential for
the transmission of the conformational changes between the
NBD and the TMD (13, 31, 32).
Comparison of the Closed Forms of BmrA Using HDX. Besides the
inhibition by vanadate, another way to promote the closed con-
formation in ABC transporters is to use catalytic inactive
mutants (8, 9, 33). For BmrA, we previously showed that the
conserved glutamate residue E504 adjacent to the Walker B
motif is very likely the catalytic base for ATP hydrolysis, because
mutation of this residue fully abrogated the activity (10, 34).
Deuterium incorporation was monitored as a function of time
and was compared for each peptide generated from the three
following forms of BmrA: wild-type in the resting state (apo
form), wild-type inhibited by vanadate (in the presence of ATP-
Mg), and E504A mutant in the presence of ATP-Mg (Fig. S5). In
some cases (e.g., in Fig. 2), spectra from the vanadate-inhibited
form showed two envelopes of isotopic peaks, thus giving two
different kinetics, with the minor envelope corresponding to that
Fig. 1. Global deuteration kinetics of BmrA. HDX was followed for BmrA in
membranes (squares) or puriﬁed in DDM (circles), either in the resting state
(open symbols) or in a vanadate-inhibited state (ﬁlled symbols). SDs for two
separate experiments are shown.
Fig. 2. Isotopic proﬁles of 203–215 peptide at two deuteration times. The
mass spectra of peptide 203–215 from ICD2 is shown before (black peaks) or
after 15 s (blue peaks) and 3,600 s (red peaks) of deuteration. This peptide
was from the wild-type BmrA in the resting state (A) or vanadate-inhibited
state (B) or from the E504A mutant incubated in the presence of ATP (C).











of the wild-type in the apo form. Presumably, this envelope
originates from BmrA dimers not inhibited among the whole
population, because the inhibition of ATPase activity by vana-
date was not total (∼80%; Fig. S1) (see also refs. 17 and 30). In
contrast, the E504A mutant showed practically only one isotopic
envelope that was always similar to that of the low molecular
mass observed in the vanadate-inhibited sample. Given the
propensity of the E504A BmrA mutant to readily adopt the
closed conformation of BmrA in the presence of ATP-Mg, and
the homogeneity of HDX of its peptides, we focused on the
differences between this mutant in the closed conformation
(ATP-bound state) and the wild-type in the apo conformation
(resting state).
Inﬂuence of the BmrA Conformation on HDX of the ICDs and NBDs.
The major differences in HDX between both forms can be vi-
sualized on the “heat map” presented in Fig. S6. The regions in
red or orange correspond to peptides with more than 45% and
30% HDX difference, respectively, after 1 h deuteration. They
clearly belong to ICD1, ICD2, and the NBD, particularly the
Walker A motif and the ABC signature, which are known to be
involved in nucleotide binding. To highlight the HDX data, two
BmrA models (28) based on the X-ray structures of homologous
bacterial ABC transporters were used (Fig. 3). For the apo
conformation of BmrA, the open structure of EcMsbA was
used as a template, whereas the closed conformation of BmrA
(mimicked by the ATP-bound E504A mutant) was modeled on
the Sav1866 structure (13, 14). In agreement with the closed
model, the regions participating in either NBD dimerization or
direct interaction with ATP/Mg show a rather low level of HDX.
This is the case, for instance, for the peptide 372–383, which
entirely covers the Walker A motif (HDX of 29%), or for the
peptide 479–492 encompassing the ABC signature (26%). In
contrast, the former peptide became much more rapidly deu-
terated in the apo conformation with a high deuteration level of
the Walker A motif (82%), consistent with the presence of
a large accessible loop, whereas the peptide covering the ABC
signature motif also showed a substantial increase in its exchange
rate (69%). The lowest value of HDX obtained for this second
peptide suggests that in the open conformation, the region likely
conserved an α-helical structure less prone to HDX than a loop.
Thus, the exchange rates for these two peptides are in agreement
with the open model used to depict the apo conformation
(Fig. 3). For other peptides of the NBDs known to be involved in
ATP binding or NBD dimerization, similar trends were ob-
served, with a faster exchange rate in the apo conformation
compared with the ATP-bound conformation (e.g., peptide 501–
509 including most of the Walker B motif). Other regions of the
NBDs not involved in either process gave similar HDX in both
conformations with, for instance, a high deuteration level con-
sistent with a loop structure (84%) for peptide 439–447.
A different picture emerges when one focuses on ICDs. In
contrast to the two models suggesting that these domains have
a similar conformation in the two states, open and closed, pep-
tides from both ICDs showed a large difference in the HDX in
these two conformations. Thus, ICD2 was highly deuterated in
the apo conformation, with 82% and 79% for peptides 203–215
and 216–236, respectively, whereas in the closed conformation
the HDX rate signiﬁcantly decreased to 33% and 34%, re-
spectively. Likewise, but to a lower extent, regions 104–114 and
115–132 from ICD1 were also fairly deuterated in the apo con-
formation (66% and 81%, respectively). This value dropped to
27% in the closed state for the former peptide, whereas it
remained highly deuterated for the latter (69%). Because the
solvent accessibility of amide hydrogens from both ICDs is es-
sentially unaffected upon the dimerization of the two NBDs (e.g.,
for peptides 104–114 and 203–215) (Fig. S7), the much faster rate
of HDX observed in the resting state for these peptides must
reﬂect a modiﬁcation of conformation and/or ﬂexibility of each
ICD. It must be noted that in the closed state, some residues of
ICD1 interact with ICD2 within the same subunit (see ref. 13)
and thus will help to restrict the motion of the two ICDs.
To further assess the ﬂexibility of these two domains in the 3D
structures of the related transporters used to model BmrA, mo-
lecular dynamics simulations of ∼100 ns were performed on
EcMsbA and Sav1866, along with that of StMsbA that was in-
cluded for comparison. After reaching a plateau for the rmsd of
the Cα for each conformation, the ﬂuctuation of the position of
the Cα atoms were calculated for the last 20 ns of the trajectories,
and the results are shown in Fig. S8. Clearly, a minor ﬂuctuation
was observed in the closed conformations of either Sav1866 or
StMsbA, regardless of the Cα considered (always below 2.5 Å). In
contrast, some basal ﬂuctuations occurred throughout the se-
quence of EcMsbA and were much more pronounced (above 4
Å) for four areas, including in particular ICD2. This suggests that
this latter domain must be quite ﬂexible in this apo conformation.
Fig. 3. HDX of peptides using BmrA 3D models. 3D models of BmrA in the open conformation (Left) or in the closed conformation (Right). One subunit was
drawn in wheat color and the other in light gray. Identiﬁed peptides are drawn with rainbow colors (in one monomer and in all ICDs) according to their
percentage of deuterium exchange after 3,600 s (scale of exchange shown at right). Selected regions are also shown with arrows.
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Discussion
The goal of this study was to get insights into the dynamics of
a multidrug ABC transporter in two different conformations: the
resting state, in which the transporter adopts presumably an open
conformation (the extent of which remains to be determined), and
the closed state, in which the two NBDs dimerize in a transient,
ATP-bound, conformation. Overall, global HDX and trypsin di-
gestion show that either in membrane or in detergent, BmrA can
switch between two very different conformations during its catalytic
cycle: a closed form rather resistant to trypsin digestion and HDX,
and another one in the resting state quite sensitive to trypsin and
more susceptible to HDX. Thus, our results support the postulate
that multidrug ABC transporters can cycle between an open, in-
ward-facing, conformation in the resting state and a closed, out-
ward-facing, ATP-bound conformation. Similar conclusions were
drawn for the catalytic cycle of MsbA from cross-linking experi-
ments (35) or from EPR spectroscopy (17, 36, 37). On the basis of
3D structures of ABC exporters, the transition between these two
opposite conformations was proposed to operate according to
a rigid bodymotion (14). This entails that the same overall structure
of the two monomers (or moieties for full-length transporters)
would bemaintained throughout the catalytic cycle. However, local
HDX obtained for BmrA clearly challenges this assumption and
suggests that in the resting state, BmrA samples different con-
formations. However, these different conformations seem to be
restricted to both ICDs. Indeed, apart from the peptides involved
either in the interactions between the two NBDs or with ATP, no
major changes are observed for the other peptides from either the
NBD or the transmembrane helices, although limited information
is available for the latter. Therefore, the interaction between the
TMD and the NBD that is secured by the two ICDs in the closed
state must become loose in the resting state owing to a greater
ﬂexibility of these ICDs. This would allow some reorientation of the
whole NBD compared with the TMD and would explain some
unexpected cross-links previously observed for BmrA. It was found
that disulﬁde bonds were formed between ICD1 and the Q-loop of
the NBD in the resting state only (20). However, in all structures of
exporters, either closed or open, ICD2 is sandwiched between
ICD1 and the Q-loop, thereby impeding the possible interaction
between these two protein segments (12–14). Hence, some re-
organization of BmrA domains would be required to allow the
cross-link between ICD1 and the Q-loop (20). Other unpredicted
cross-links questioning the conformation observed in 3D structures
were also reported for two other ABC transporters, TAP1/TAP2
and Yor1p (15, 21). These results lend support to additional con-
formations of these transporters, with different orientations of the
NBD relative to ICDsor of the two ICDswith respect to each other.
Other studies performed on homodimeric ABC transporters,
LmrA and MsbA, using either solid-state NMR or EPR spectros-
copy, reached similar conclusions of alternative conformations (or
greater ﬂexibility) of theNBD in the resting state, as opposed to the
TMD (36, 38). In addition to the NBD ﬂexibility, EPR experiments
also support a large conformational entropy of residues from ICD1
in the resting state, as evidenced by the large distance distribution of
the spin label probe tethered to residue 115 of MsbA (36). Un-
fortunately, the ﬂexibility of ICD2 could not be tested because the
tethering of a spin probe to cysteine residues in this domain was
detrimental to MsbA activity (37). For the cystic ﬁbrosis trans-
membrane conductance regulator (CFTR), although cross-link
patterns support a global architecture similar to that found in
Sav1866 or MDR1, a considerable ﬂexibility at the interface of
NBDs and ICDs was proposed to explain the formation of cross-
links between these two domains, even with long cross-linker re-
agent (up to 24.7Å) (16). In addition, a recent report using a genetic
screen with the yeast ABC multidrug transporter PDR5 supports
the idea of a noncanonical coupling between theNBDand the TMD
as being mainly achieved through ICD1 and not through ICD2 (39).
Whether this is a peculiar property of PDR5or reﬂects an alternative
conformation of the ICDs remains to be investigated. Interestingly,
a molecular dynamics study of Sav1866 indicated that in a closed
conformation and among residues whose Cα show the largest dis-
placement between the ATP and ADP+Pi bound states, some be-
long to ICD2 (residues 221–222) and to ICD1 (residues 110–113)
(40). Here, molecular dynamics simulations suggest that in the apo
conformation of EcMsbA, large ﬂuctuations in the positions of the
Cα atoms of ICD2 would take place. Conformational ﬂexibility, and
in particular of α-helices, has been reported for some membrane
proteins, such as the lactose permease (41, 42), the osmoprotectant
symporter ProP (43), and the glycerol facilitator (44), and this
property likely pertains to the transport of their respective substrates
(45). For multidrug ABC transporters, the ﬂexibility of ICDs might
not only be involved in the transport mechanism but possibly also
permits the polyspeciﬁcity of drug recognition, provided that this
ﬂexibility could be propagated to the drug-binding site(s).
HDX coupled to MS is commonly used to probe the dynamics
of soluble proteins, but this technique remains artful in the case of
membrane proteins, especially because detergent often reduces
the sequence coverage. Up to now, the only ABC transporter for
which this technique was used was the soluble NBD1 of CFTR
(46). However, our results on BmrA emphasize how useful this
technique is, especially to study membrane proteins with large
extramembranous domains. This includes, for example, secondary
transporters of the resistance-nodulation-cell division family, such
as AcrB (47), or primary transporters of the P-type family like the
Ca2+-ATPase (48). The use of HDX coupled to MS to unravel
different conformations of these membrane proteins should shed
new light on their transport mechanism.
Materials and Methods
Site-Directed Mutagenesis and Puriﬁcation of BmrA. The E504A BmrA mutant
was constructed as previously described (10). The E504Amutant andwild-type
BmrA were overexpressed as previously described (49), and BmrA-enriched
membranes were either frozen in liquid nitrogen and kept at −80 °C until
used or solubilized in 1% DDM. After solubilization, BmrA was puriﬁed by
Ni-afﬁnity chromatography as previously described (29).
HDX of BmrA. The HDX reaction was initiated by a 10× dilution into deu-
terated buffer containing 50 mM NaCl and 0.05% DDM. Time course of the
HDX was followed over a 1-h period by sequential withdrawing of 120 μL
deuterated samples, which were immediately added to 26 μL of quenching
buffer (8 M guanidium chloride, 500 mM glycine HCl, pH 2.2), rapidly mixed,
and ﬂash-frozen in liquid nitrogen.
HPLC Peptide Separation. After protease digestion in solution or on-column in
an ice bath at 0 °C, peptides were loaded onto a peptide MicroTrap (Michrom
Bioresources) column andwashedwith 0.03% TFA inwater (HPLC solution A).
They were then separated on a reversed-phase C12 column (1 × 50 mm, Ju-
piter; Phenomenex) using a linear gradient of 15–45% (vol/vol) solution B
(CH3CN 95%and TFA 0.03%) during 26min. The columnwas connected to the
electrospray source of mass spectrometers until 30% (vol/vol) B and then
disconnected to avoid pollution of the electrospray source by the detergent.
The valves, trap cartridge and column were cooled to 0 °C by immersion in an
ice bath.
Mass Spectrometric Analyses of Peptides. The tandemMS (mapping) analyses
were performed on an ion trap mass spectrometer (Esquire 3000+; Bruker
Daltonics) to enable the identiﬁcation of the peptides after their sepa-
ration on HPLC. Accurate mass measurements and the analysis of the local
kinetics of deuteration were done on a time-of-ﬂight (TOF) mass spec-
trometer (6210; Agilent Technologies) equipped with an electrospray
source. Data were processed withMassHunter Qualitative Analysis, and the
deconvolution and calculation of the average masses were carried out in
Magtran (50).
Electrospray Mass Spectrometry of the Full-Length Protein. Themolecularmass
of the intact protein was measured with the same electrospray TOF mass
spectrometer coupled with HPLC. Protein was loaded onto a protein MicroTrap
(Michrom Bioresources) column and washed with 0.03% TFA in water (HPLC











solutionA). Theproteinanddetergentwere thenseparatedona reversed-phase
C18 column (1× 50mm, Jupiter; Phenomenex) using a linear gradient of 5–60%
(vol/vol) solution B (95% CH3CN, 4.97% water, and 0.03% TFA) during 3 min.
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SI Results
Electrospray Mass Spectrometry of the Full-Length Protein. Because
lipids and detergents either give strong signals in mass spec-
trometry (MS) or disturb the protein ionization in the electro-
spray source (1), they must be separated from the protein before
reaching the source. Previous separations involved gel electro-
phoresis and electroelution (2), protein precipitation and re-
suspension in concentrated acidic solutions (3), or size exclusion
chromatography after dissolution in a chloroform/methanol/acid
solution (4). However, although efﬁcient, all these methods were
hardly compatible with the requirement of a fast preparation of
the samples to limit as much as possible the back exchange re-
action after deuterium incorporation into BmrA. Therefore,
chromatographic parameters were ﬁrst optimized to separate
membrane lipids or n-dodecyl-β-D-maltoside (DDM) detergent
from the protein using classical reversed phase chromatography
(Materials and Methods).
Because of the cloning strategy used (5), puriﬁed BmrA was
expected to contain three additional residues on its N terminus
(sequence MASMPT. . ., with the underlined residues corre-
sponding to the beginning of the native protein) and 15 addi-
tional residues on its C terminus, including the Histidine tag
(sequence . . .KAGVDKLAAALEHHHHHH, with the under-
lined residues corresponding to the end of the native protein).
Thus, the deconvoluted mass obtained is in very good agreement
with the calculated mass of BmrA, possessing only one extra Ser
amino acid on its N terminus (66,340 Da). Masses of a second
peak (66,412 Da, in membranes) are also in very good agreement
with the calculated mass of BmrA, with two extra amino acids on
its N terminus, Ala plus Ser (66,411 Da). Therefore, the ﬁrst
methionine and sometimes also the second amino acids (Ala) of
the N terminus of the proteins were very likely cleaved off by
proteolysis during the puriﬁcation process. The high quality of
each spectrum reﬂects the efﬁciency of the chromatographic
separation upstream of the electrospray source for either sample.
Mass Spectrometric Analyses of Peptides. To localize the difference
in deuterium incorporation between the two conformations of
BmrA, the protein digestion occurred at low pH and low tem-
perature, and the peptide separations were optimized (Materials
and Methods). This step was essential to reach a sequence cov-
erage of the protein as large as possible with peptides as small as
possible (6). However, DDM used for BmrA puriﬁcation gave
a very strong signal in MS. To enable observation of the mass
spectra originating from the peptides, a protocol previously de-
veloped in our group for another membrane protein puriﬁed in
Triton X100 was ﬁrst attempted without success (7). Reversed-
phase separation was then adjusted so that all peptides eluted
before the detergent, at low temperature to limit deuterium
back-exchange. For peptides sequencing using tandem MS, the
chromatographic parameters were chosen for a good separation
to facilitate their identiﬁcation, and the detergent still eluted
after the last peptides. For the analysis of deuterated peptides,
the elution times were also shortened as much as possible to
limit deuterium back-exchange. Pepsin and rhizopuspepsin (8)
were used independently to digest BmrA. The pepsin digestion
in solution yielded only 31 peptides, covering 45% of the BmrA
sequence (Table S1). However, the use of immobilized pepsin
signiﬁcantly increased the number of peptides (67), and thus the
sequence coverage increased to 78%. These results were ob-
tained in the presence of 1.5 M guanidinium hydrochloride
(GndCl), a denaturant concentration that was optimized after
different trials between 0.5 and 4 M. However, the low coverage
of the hydrophobic transmembrane helices is presumably due to
the presence of the detergent that might afford protection
against the protease digestion. Immobilized rhizopuspepsin was
also used for on-line digestion of BmrA. The goal was to obtain
complementary sequence coverage to improve spatial resolution
by the occurrence of overlapping peptides. The number of
peptides and the sequence coverage were signiﬁcantly lower in
the transmembrane domain (TMD) in comparison with immo-
bilized pepsin (Fig. S4 and Table S1). In the nucleotide-binding
domain (NBD), the coverage seemed quite complementary to
the one obtained by pepsin. However, after deuteration a sig-
niﬁcant number of peptides were lost with each protease,
a phenomenon that is frequently observed in hydrogen/deute-
rium exchange (HDX) (9). This is due to a heterogeneous
deuteration that induces a broadening of the MS signal, and thus
a decrease in its intensity. The loss was much higher in the case
of rhizopuspepsin, which was also less efﬁcient than pepsin.
SI Materials and Methods
Materials.Unless speciﬁed, chemicals and pepsin were purchased
from Sigma-Aldrich. DDM was purchased from Anatrace.
Site-Directed Mutagenesis and Puriﬁcation of BmrA. Protein con-
centrations were estimated by using a modiﬁed Lowry method
(10) for BmrA-enriched membranes, or the Bradford method
(11) after puriﬁcation. The accurate masses of the puriﬁed mu-
tant and wild-type proteins were checked using electrospray MS.
Pepsin Digestion.All protein digestions in solution were performed
in an ice bath at 0 °C. Protease solutions were prepared in
500 mM glycine (pH 2.2) and cooled to 0 °C. BmrA was digested
in the same buffer for 2–5 min using a protease/substrate ratio of
1:1 or 1:10 (wt/wt) for pepsin and rhizopuspepsin, respectively.
Increase in digestion time did not have any effect on the pro-
teolysis. On-line digestions in the presence of 0.5–4 MGndCl were
also performed in an ice bath at 0 °C using columns packed with
rhizopuspepsin or pepsin immobilized on POROS-AL resin (8).
Limited Proteolysis of BmrA. BmrA was submitted to trypsin di-
gestion at a protease/substrate ratio of 1:1,000 (wt/wt). For BmrA
solubilized in detergent a reaction mixture of 100 μL was pre-
pared, and aliquots of 10 μL were withdrawn after 5, 15, and 30
min. For the vanadate-inhibited state, 5 mM ATP, 5 mM MgCl2,
and 3 mM vanadate were added to the protein solution and
incubated for 15 min at room temperature before adding trypsin.
For digestion of BmrA-enriched membranes, a reaction mixture
of 100 μL was prepared, and aliquots of 10 μL were withdrawn
after 5, 15, and 30 min, 1 h, 2 h, and 3 h. Each aliquot was
acidiﬁed with 1 μL of 5% TFA and immediately frozen in liquid
nitrogen. SDS/PAGE (12.5%) was resolved, followed by Coo-
massie blue staining.
HDX of BmrA. The vanadate-inhibited state of the wild-type BmrA
was prepared as above for limited proteolysis experiments. The
E504Amutant was ﬁrst incubated for 10 min with 5 mMATP and
5 mM MgCl2.
ATPase Activity. To measure the ATPase activity of BmrA in
detergent, an enzymatic coupled assay system was used, in the
presence of 0.05% DDM and as described previously (12). The
activity was measured in the presence of 10–20 μg of BmrA and
followed at 37 °C for 10 min. When vanadate was present, it was
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added at a ﬁnal concentration of 3 mM from a 100-mM stock
solution (see ref. 12).
Calculation of Accessibility Areas of Peptides. The solvent accessi-
bility area of BmrA peptides was calculated with the help of
naccess. This software, based on the method of Lee and Richards
(13), calculates the solvent-accessible area of a protein structure
in a Protein Data Bank (PDB) format. Then, on the basis of the
accessibility of each atom, the total access area of the main chain
atoms was determined. To compare the solvent accessibility val-
ues with HDX MS data, the mean solvent accessibility area of
individual peptides was determined by taking into account the
main chain atoms only. Because region from residue 325 to res-
idue 332 shows the most solvent-accessible surface in both
models, the values for all other peptides were normalized con-
sidering the peptide 325–332 as a 100% solvent-accessible region.
Molecular Dynamics (MD) Simulations. MD trajectories were simu-
latedwith version 2.7 ofNAMD(14), using theCHARMM27 force
ﬁeld with CMAP corrections (15), and the TIP3 (transferable in-
termolecular three-point) model for water molecules (16). All of
the simulations were performed in the NpT ensemble. The pres-
sure wasmaintained at 1 atmusing aNose-Hoover Langevin piston
control (17), with period of 100 fs and damping time constant of
50 fs. Temperature was maintained at 300 K by coupling to
a Langevin thermostat, with damping coefﬁcient of 5 ps−1. Elec-
trostatic interactions were treated by the Particle Mesh Ewald al-
gorithm (18), with grid spacing lower than 1 Å. Smoothed cutoff
(10–12 Å) was used for the van der Waals interactions. Equations
of motion were integrated with a time step of 2 fs. The SETTLE
algorithm was used to restrain hydrogen atoms (19).
Three systems were considered: (i) the Sav1866 multidrug
transporter from Staphylococcus aureus at 3.0 Å in an outward-
facing conformation reﬂecting the ATP-bound state (20), (ii) the
MsbA lipid “ﬂippase” either from Escherichia coli in the open
apo-conformation at 5.3 Å, or (iii) from Salmonella typhimurium
in the outward-facing conformation at 3.7 Å (21). The structures
were deﬁned according to PDB ﬁles 2HYD, 3B5W, and 3B60,
respectively, together with the crystallographic water molecules.
Only the Cα-trace structure is available in 3B5W. Missing backbone
and side-chain atoms were predicted using MAXSPROUT (22)
and SCWRL (23). An acetyl group was attached to the N terminus
residue to mimic the preceding peptide bond, and the C-terminal
carboxylate was protonated. Default ionization states at pH 7 were
set, except for buried residues whose ionization states were de-
termined using WHATIF (24) and visual inspection. The proteins
were centered in the x–y plane, with the permeation pathway
aligned to the z axis, and embedded in a preequilibrated bilayer of
569 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) molecules.
The upper layer of the lipid membrane was aligned to the center of
mass along z of the aromatic residues of the extracellular side
(Phe158, Phe157, Tyr39, and Tyr268 in Sav1866, and Trp165,
Trp66, Tyr162, Tyr168, Phe157, Phe265, and Phe272 in MsbA).
Lipid molecules closer than 1.2 Å to protein atoms were removed.
Sodium and chloride ions were added to neutralize the system (up
to a ﬁnal concentration of 150 mM). The ﬁnal systems contain
∼195,000 atoms in the Sav1866 simulation (∼41,800 TIP3P water
molecules, 360 DOPC lipids, 61Cl− and 59Na+), ∼202,000 atoms in
the simulation of MsbA PDB 3B60 (∼42,800 TIP3P water mole-
cules, 402 DOPC lipids, 55Cl− and 63Na+), and ∼244 atoms in the
simulation of MsbA PBD 3B5W (∼53,500 TIP3P water molecules,
472 DOPC lipids, 71Cl− and 79Na+).
To equilibrate the atoms around the transporters, 2,000 steps of
energy minimization and 1 ns of MD were performed with
restraints applied to the backbone atoms of the protein.
Restraints were initially set to 10 kcal*mol−1*Å−2, and gradually
reduced to zero. Unrestrained MD simulation followed for ∼82
ns (MsbA 3B5W), ∼88 ns (MsbA 3B60), and ∼93 ns (Sav1866).
The atomic systems used for the analyses were from the last 20
ns of the unrestrained MD. A signiﬁcant drift that stabilizes at
6.7 ± 0.2 Å after 60 ns and remains constant until the end of the
simulation is observed in the rmsd of MsbA (3B5W). The rmsd
values of the MsbA (3B60) and Sav1866 simulations reached
a plateau in less than 3 ns, with average values of 2.4 ± 0.1 Å and
1.9 ± 0.1, respectively.
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Fig. S1. ATPase activity of the wild-type BmrA. BmrA (10–20 μg) was injected into an ATPase assay medium in the absence (blue bar, WT) or presence of 3 mM






























































Fig. S2. Raw mass spectra of BmrA in membranes (A) or BmrA puriﬁed in DDM (B). Deconvoluted mass spectra are presented in First Insets with a close-up
view in Second Insets.





















Fig. S3. SDS/PAGE of BmrA-enriched membranes or BmrA puriﬁed in DDM and after limited proteolysis with trypsin. BmrA in membranes in the apo con-
formation (A) or in the vanadate-inhibited conformation (B) and after incubation with trypsin for 5 min, 15 min, 30 min, 1 h, 2 h, and 3 h (from left to right
lanes); (C) BmrA puriﬁed in detergent in the apo conformation (lanes 3–5) and in the vanadate-inhibited conformation (lanes 6–8) and after incubation with
trypsin for 5, 15, and 30 min (from left to right lanes). C is the control lane with no trypsin added, with the black arrowhead showing the position of the full-
length BmrA. The masses of the molecular weight markers (MW) are indicated in kDa.









Fig. S4. Peptide mapping of BmrA using immobilized pepsin (blue) or immobilized rhizopuspepsin (red). The predicted secondary structure (cylinders for
α-helices and arrows for β-strands) and topology of BmrA based on the Sav1866 3D structure is shown above the sequence with the speciﬁc regions: Walker A
(WA) and B (WB) motifs and the ATP-binding cassette signature. The transmembrane helices 1–6 (TMH1 to -6) are shown in green, and the positions of the
intracellular domains 1 and 2 (ICD1 and ICD2, respectively) are indicated. The extracellular parts of BmrA are shown in gray. The boundary between the TMD
and the NBD is shown by a vertical dotted line. The ﬁgure was drawn with the help of the MS Tools application (1).
1. Kavan D, Man P (2011) MSTools—Web based application for visualization and presentation of HXMS data. Int J Mass Spectrom 302:53–58.
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Fig. S5. (Continued)
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Fig. S5. HDX kinetics of all BmrA peptides identiﬁed after digestion with immobilized pepsin. The percentage of deuteration is plotted against different
deuteration times for the wild-type BmrA in the apo state (blue circles), in the vanadate-inhibited state (green triangles), or in the mutated (E504A) form (red
circles). SDs (for two experiments) are shown by vertical bars; in many cases, bars are so small that they are hidden by the symbols; in the vanadate-inhibited
state, the ﬁrst isotopic envelope was sometimes too tiny or too close to the second one to be deconvoluted, and the kinetics could not be drawn with certainty.













Fig. S6. Heat map showing the difference in deuterium incorporation between the apo conformation (wild-type in the resting state) and the closed con-
formation (E504A in the presence of ATP) after 1 h deuteration. The predicted secondary structure and topology of BmrA (see legend to Fig. S4) is indicated
above the sequence. Colors deﬁned in key at lower right.












































Fig. S7. Comparison of deuterium incorporation and solvent accessibility areas in both conformations of BmrA, open (A) or closed (B). Panels at Left are
identical to those shown in Fig. 3 for the HDX, except that only the selected peptides are colored according to the deuterium exchange scale. Right: Solvent
accessibility of the corresponding peptides deduced from each BmrA model and using naccess software (details in SI Materials and Methods).

















ABC WBWA    ICD1 ICD2
Fig. S8. Root mean square ﬂuctuation of the Cα of Sav1866, StMsbA, and EcMsbA. Molecular dynamics simulations were performed on each structure and,
once equilibrium was reached, the rms ﬂuctuation in Å was calculated for the last 20 ns and is shown as a function of the residue number. The predicted
topology of BmrA is also shown on top of the ﬁgure for comparison (see legend to Fig. S4 for color coding).
Table S1. Sequence coverage, number of peptides, and average
size of the peptides for BmrA and for its domains TMD and NBD
obtained in different digestion conditions and after deuteration
and digestion with immobilized pepsin
Condition BmrA TMD NBD
Pepsin column
% coverage 78 60 98
Peptides 67 24 43
Average 7.0 8.0 6.4
Pepsin in solution
% coverage 45 11 82
Peptides 31 3 28
Average 8.7 12.6 8.3
Rhizopuspepsin column
% coverage 50 10 84
Peptides 52 8 44
Average 5.8 8.0 5.4
HDX
% coverage 67.5 45 92
Peptides 44 15 29
Average 9.3 9.0 9.3
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